On 14 July 2026, the European Parliamentary Research Service (EPRS) published a comprehensive briefing on PFAS (per- and polyfluoroalkyl substances), also known as ‘forever chemicals’. The document is intended to serve as a technical basis for MEPs in their upcoming political decisions on PFAS regulation and summarises the current state of scientific knowledge, regulation and procedures.

What is the problem?

Due to their favourable physico-chemical properties, PFAS are valuable for countless applications and products – including in the pharmaceutical sector. On the other hand, they pose an enormous challenge to the environment and human health: PFAS are persistent and have been detected worldwide in soil, water, food, wildlife and humans. Given the extent of contamination and the limitations of technically complex and costly remediation, scientists and regulatory authorities regard preventing further environmental pollution – i.e. regulating PFAS at source – as the most sustainable option.

What solutions are being discussed?

Due to the vast number of PFAS, regulating each individual compound is not feasible. The EU Chemicals Strategy for Sustainability therefore proposes regulating PFAS as a group. The European Chemicals Agency is currently reviewing a draft restriction under the EU Regulation on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), which covers around 10,000 compounds.

This would, in principle, prohibit the manufacture, placing on the market and use of PFAS, but provides for transition periods and sector-specific exemptions for applications where no suitable alternatives are currently available.

What happens next?

The European Chemicals Agency is expected to submit its final opinion to the European Commission by the end of 2026. The European Parliament will examine the Commission’s draft restriction. The European Commission will then present a concrete regulatory proposal for further deliberation.
The EPRS briefing highlights the key conflict of objectives:
Reducing risks to the environment and health through far-reaching restrictions
Whilst safeguarding critical applications and taking strategic industrial sectors into account

Reference:

https://www.gmp-publishing.com/blog/eu-forever-chemicals-in-a-conflict-of-interests

READ MORE
Exim rebrands as ExSyn: We celebrate our 30-year heritage with a new brand and website that bring alive our values and purpose
News · 27/03/2021

Today we announce that Exim is rebranding as ExSyn. We are presenting a new brand identity and website as a reflection of our relentless transformation over the course of 30 years serving the pharma and chemical industries. The new brand builds upon our core strengths as a sourcing company and captures our most essential duty: helping improve people’s health and lives.

In focus: CMS-P (Vinylbenzyl chloride)
Products in focus · 17/11/2026

Vinylbenzyl chloride, commonly referred to as CMS-P, is typically an equimolar mixture of meta and para chloromethyl styrenes. CMS-P is a bifunctional monomer, featuring both a polymerizable vinyl group and a reactive benzylic chloride functionality. It is widely used as an intermediate in synthesis of specialty polymers and can readily copolymerize with various monomers, making it valuable in the production of advanced and specialty plastics.

In focus: N,N′-Dimethylethylenediamine   
Products in focus · 10/11/2026

N,N′-Dimethylethylenediamine (DMEDA) is an organic chemical compound belonging to the diamine family. It contains two nitrogen atoms, each bearing a methyl group, connected by a two-carbon chain.

Global Freight Costs Surge 130%
News · 03/11/2026

Global shipping costs have climbed to $4,000–$4,500 in October from $2,000–$2,500 in February 2026. Freight rates, which had eased through much of 2025 and early 2026 as the demand-supply balance improved, have rebounded sharply in recent months. The increase has brought shipping costs back into focus for businesses dependent on international cargo movement.